[질문] http://biohavenpharma.com/biohaven-completes-randomization-in-phase-23-trial-in-spinocerebellar-ataxia-expected-topline-data-advanced-to-fourth-quarter-of-2017/이글 읽으시고 이건 몇번째고 NDA시작 한건가요? BHV4157은 고아약이자 패스트트랙이고요